Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey

被引:26
|
作者
Zhou, Yang [1 ]
van den Hof, Susan [2 ,3 ]
Wang, Shengfen [1 ]
Pang, Yu [1 ]
Zhao, Bing [1 ]
Xia, Hui [1 ]
Anthony, Richard [4 ]
Ou, Xichao [1 ]
Li, Qiang [1 ]
Zheng, Yang [1 ]
Song, Yuanyuan [1 ]
Zhao, Yanlin [1 ]
van Soolingen, Dick [4 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
[2] KNCV TB Fdn, The Hague, Netherlands
[3] Amsterdam Med Ctr, Dept Global Hlth, Pietersbergweg 17, Amsterdam, Netherlands
[4] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
LARGE SEQUENCE POLYMORPHISMS; GENETIC DIVERSITY; BEIJING GENOTYPE; EVOLUTION; ORIGIN; CLONE; SUBLINEAGES; PULMONARY; RIFAMPIN; INSIGHTS;
D O I
10.1371/journal.pone.0174197
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe the population structure of a representative collection of 3,133 Mycobacterium tuberculosis isolates, collected within the framework of a national resistance survey from 2007 in China. Genotyping data indicate that the epidemic strains in China can be divided into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these strains has spread national wide. The density of Beijing strains is high in the whole of China (average 70%), but the highest prevalence was found North of the Yellow river. The Euro-American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more prevalent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly higher level of resistance to rifampicin (14%, p < 0.001), ethambutol (9%, p = 0.001), and ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the highest cluster rate (28%) and presented a significantly elevated level of resistance to streptomycin (44%, p < 0.001). Our findings suggest that standardised treatment in this region may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-American lineage may have thrived when streptomycin was used without rifampicin for treatment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing lineage appears to be spreading.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru
    Grandjean, Louis
    Iwamoto, Tomotada
    Lithgow, Anna
    Gilman, Robert H.
    Arikawa, Kentaro
    Nakanishi, Noriko
    Martin, Laura
    Castillo, Edith
    Alarcon, Valentina
    Coronel, Jorge
    Solano, Walter
    Aminian, Minoo
    Guezala, Claudia
    Rastogi, Nalin
    Couvin, David
    Sheen, Patricia
    Zimic, Mirko
    Moore, David A. J.
    PLOS ONE, 2015, 10 (05):
  • [2] Spoligotyping and Drug Resistance Analysis of Mycobacterium tuberculosis Strains from National Survey in China
    Pang, Yu
    Zhou, Yang
    Zhao, Bing
    Liu, Guan
    Jiang, Guanglu
    Xia, Hui
    Song, Yuanyuan
    Shang, Yuanyuan
    Wang, Shengfen
    Zhao, Yan-lin
    PLOS ONE, 2012, 7 (03):
  • [3] Beijing genotype of Mycobacterium tuberculosis is less associated with drug resistance in south China
    Zhao, Li-Li
    Li, Ma-Chao
    Liu, Hai-Can
    Xiao, Tong-Yang
    Li, Gui-Lian
    Zhao, Xiu-Qin
    Liu, Zhi-Guang
    Wan, Kang-Lin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (06) : 766 - 770
  • [4] Mycobacterium tuberculosis Beijing Strains Favor Transmission but Not Drug Resistance in China
    Yang, Chongguang
    Luo, Tao
    Sun, Guomei
    Qiao, Ke
    Sun, Gang
    DeRiemer, Kathryn
    Mei, Jian
    Gao, Qian
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (09) : 1179 - 1187
  • [5] Genetic Diversity and Primary Drug Resistance of Mycobacterium tuberculosis Beijing Genotype Strains in Northwestern Russia
    Vyazovaya, Anna
    Gerasimova, Alena
    Mudarisova, Regina
    Terentieva, Daria
    Solovieva, Natalia
    Zhuravlev, Viacheslav
    Mokrousov, Igor
    MICROORGANISMS, 2023, 11 (02)
  • [6] Prevalence of Mycobacterium tuberculosis Beijing genotype and its association drug resistance in North India
    Mathuria, Jitendra P.
    Srivastava, Govind N.
    Sharma, Pragya
    Mathuria, Bharat L.
    Ojha, Sanjay
    Katoch, Vishwa M.
    Anupurba, Shampa
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2017, 10 (04) : 409 - 414
  • [7] Spoligotyping and drug-resistance of Mycobacterium tuberculosis strains from Shanxi province, China
    Gong, Yane
    Gao, Ning
    Guo, Buping
    Liu, Haican
    Du, Xiaoli
    Liu, Yiping
    Zhang, Jianbin
    Li, Hui
    Li, Shuixian
    Zhao, Bo
    Bo, Hongxia
    Wan, Kanglin
    Pang, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 5978 - 5983
  • [8] Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis
    McGrath, M.
    Gey van Pittius, N. C.
    van Helden, P. D.
    Warren, R. M.
    Warner, D. F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) : 292 - 302
  • [9] Characterization of Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility phenotypes and Beijing genotype family transmission
    Liu, Yi
    Zhang, Xuxia
    Zhang, Yuqing
    Sun, Yong
    Yao, Cong
    Wang, Wei
    Li, Chuanyou
    BMC INFECTIOUS DISEASES, 2018, 18
  • [10] Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes
    Nhu, N. T. Q.
    Lan, N. T. N.
    Phuong, N. T. N.
    Chau, N. van V.
    Farrar, J.
    Caws, M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (04) : 527 - 531